Udagawa, S., Ishizuka, C., Osumi, H., Hirose, T., Okita, N., Hirano, H., . . . Shinozaki, E. (2026). Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: A multicenter real-world study. International Journal of Clinical Oncology, 1-10. https://doi.org/10.1007/s10147-026-03181-1
Παραπομπή σε μορφή Chicago (17η εκδ.)Udagawa, Shohei, et al. "Proteinuria as the Cause of Early Dose Modification in Japanese Patients with Metastatic Colorectal Cancer Treated with Fruquintinib: A Multicenter Real-world Study." International Journal of Clinical Oncology 2026: 1-10. https://doi.org/10.1007/s10147-026-03181-1.
Παραπομπή σε μορφή MLA (9th εκδ.)Udagawa, Shohei, et al. "Proteinuria as the Cause of Early Dose Modification in Japanese Patients with Metastatic Colorectal Cancer Treated with Fruquintinib: A Multicenter Real-world Study." International Journal of Clinical Oncology, 2026, pp. 1-10, https://doi.org/10.1007/s10147-026-03181-1.